Related Experiment Video
Updated: Jan 28, 2026

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
Published on: September 16, 2022
The Emerging Role of Liquid Biopsies in Lymphoproliferative Disorders
Jennifer Crombie1, Philippe Armand2
1Dana-Farber Cancer Institute, Boston, MA, USA. jennifer_crombie@dfci.harvard.edu.
Purpose Of The Review:
Lymphomas represent clinically and molecularly heterogeneous diseases with variable presentations, treatment algorithms, and outcomes. As treatment options continue to expand, more sophisticated prognostic and predictive biomarkers are needed to guide personalized treatment approaches.
Recent Findings:
Liquid biopsies, in which the sequencing of circulating tumor DNA (ctDNA) in peripheral blood serves as a surrogate for a tumor biopsy, are now being studied across cancer subtypes, including in lymphoid malignancies. Recent studies have demonstrated the potential of these techniques to improve prognostication and guide individualized treatment strategies, providing a significant advance in the field of precision medicine. In this review, we describe the sequencing platforms currently available for analysis of ctDNA in lymphoma and their potential applications in clinical practice, which seem poised to refine treatment paradigms across lymphoma subtypes.
Related Concept Videos
Emerging Adulthood
Intrinsically Disordered Proteins
Introduction Cardiac Emergencies
Applications of GIS: Disaster Management and Emergency Response
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture

